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Objective. This study demonstrated that magnesium (Mg)
reduces free radicals after a brief coronary occlusion-reperfusion
sequence.
Background. Magnesium has been shown to reduce infarct size
in patients with acute myocardial infarction. We hypothesized
that this action of Mg occurs through its action on free radicals.
Methods. Eighteen mongrel dogs were studied (nine control,
nine receiving Mg). Catheters were placed into the coronary sinus
for continuous blood withdrawal. A Varian E-4 electron paramag-
netic resonance spectrometer was used to monitor the ascorbate
free radical (AFR) signal in the coronary sinus blood; AFR is a
measure of total oxidative stress. Occlusion of the left anterior
descending coronary artery for 20 min was followed by reperfu-
sion. The study animals received 4 g Mg intravenously starting at
15 min of occlusion (5 min before reperfusion) and continuing
during reperfusion.
Results. Results are presented as percent change from base-
line 6 SEM. Magnesium blunted the peak AFR increase: at 4 min
of reperfusion there was a 4.7 6 3.3% increase in AFR signal in
the dogs receiving Mg versus an 18.2 6 3.3% increase in the
control animals (p < 0.05). Total radical flux was reduced during
reperfusion by 53% in the Mg dogs compared with controls (p <
0.05).
Conclusions. Magnesium attenuates AFR increase after an
occlusion-reperfusion sequence. To our knowledge this is the first
in vivo real-time demonstration of Mg’s impact on free radicals.
(J Am Coll Cardiol 1998;32:536–9)
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Rapid restoration of coronary blood flow after coronary artery
occlusion provides a significant decrease in infarct size and
mortality. However, early reperfusion is associated with reper-
fusion injury due primarily to calcium overload and oxygen
free radicals generated by reintroduction of molecular oxygen
into the ischemic myocardium (1,2).
Attenuation of both free radical increase and calcium
overload may limit reperfusion injury (3–5). Clinical studies
suggest magnesium (Mg) has beneficial effects in patients with
acute myocardial infarction by preserving left ventricular ejec-
tion fraction, decreasing infarct size and limiting mortality
(6–8). This has been postulated to occur through the effect of
Mg as a physiologic calcium channel blocker (9). Whether Mg
can attenuate free radicals as well is uncertain; there are few
data evaluating the effect on free radicals of Mg administered
to a whole animal during occlusion-reperfusion sequences.
This study sought to evaluate the hypothesis that Mg reduces
free radicals during an occlusion-reperfusion sequence in a
canine model.
Methods
This study was approved by the Animal Care and Use
Review Board at The University of Iowa and conformed to all
regulations for animal use. Eighteen mongrel dogs (nine
control/nine receiving Mg), weighing between 23 and 27 kg,
were studied.
Experimental preparation. The dogs were anesthetized
with a ketamine/rompin (both 100 mg/mL) 3:1 combination at
1 ml/9 kg, intubated and ventilated. Arterial blood gases were
monitored and ventilator settings adjusted as necessary. Anes-
thesia was maintained with intravenous pentobarbital as
needed. Sixteen of the 18 dogs underwent a left lateral
thoracotomy with exposure of the heart. The left anterior
descending (LAD) coronary artery and mid- to distal coronary
sinus (CS) were isolated by dissection and snare ligatures were
placed. The LAD coronary arterial ligature was placed proxi-
mal to the first visible epicardial diagonal branch. A Dacron-
woven catheter (7F Gensini) was manually placed into the CS
via the right external jugular vein, downstream from the great
cardiac vein, to sample the venous drainage from the area of
subsequent ischemia-reperfusion (anterior left ventricular
myocardium) and secured in position by the snare ligature. We
tried to achieve identical catheter placement in all dogs. The
remaining 2 dogs had percutaneous instrumentation without a
thoracotomy; in these two, the woven Dacron catheter was
placed into the CS under fluoroscopic guidance and anchored
in position at its exit from the sheath. A 2.5- or 3.5-mm
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angioplasty balloon catheter was positioned in the LAD artery
proximal to the diagonal branch for the later coronary
occlusion-reperfusion sequence.
Ascorbate-free radical measurements. We measured
ascorbate free radical (AFR) signals in the CS or femoral
artery as a parameter of total oxidative stress. Our in vivo,
real-time method has been previously described in detail (10).
Normally, the AFR signal at baseline is below the limit of
detection. Therefore, the baseline AFR concentration was
enhanced by a continuous vitamin C (ascorbate) infusion at an
appropriate rate that produced a steady-state AFR electron
paramagnetic resonance (EPR) signal in both the femoral
artery and CS. A Varian E4 EPR spectrometer was used to
measure the amplitude of the characteristic AFR signal; the
amplitude is proportional to the concentration of AFR in the
blood. Once a stable signal ('8 nM) was obtained, the
ascorbate infusion was held constant. Sampled blood was
continuously drawn from the CS or femoral artery and passed
through the spectrometer at a constant rate and then returned
to the dog via the femoral vein. The total time for blood to
traverse the catheter to the electron paramagnetic spin reso-
nance device was 5 s.
Experimental protocol. Once a stable AFR signal was
achieved, occlusion of the LAD coronary artery was accom-
plished by snare occlusion or balloon inflation; subsequent
reperfusion was accomplished by snare release or balloon
deflation. The absence of coronary flow on occlusion was
documented through loss of coronary Doppler flow signals,
measured using an epicardial Doppler flow probe in the dogs
undergoing thoracotomy, and by loss of measurable blood
pressure from the intracoronary angioplasty catheter in the
closed-chest dogs. The coronary occlusion period was 20 min
as was the reperfusion period. The study animals received
2 g Mg (as Mg sulfate) IV over 5 min starting at min 15 of
occlusion. Without interruption, the study dogs received an
additional 2 g Mg over the first 12 minutes of reperfusion
during which time the coronary sinus AFR signals were
measured (see later). These Mg doses were based on published
Mg data (i.e., Intravenous Magnesium Intervention Trial-2)
(8) adjusted for the animal weights. The control dogs received
a saline infusion.
AFR signals were obtained via continuous CS sampling
during the occlusion-reperfusion period, as previously de-
scribed. During the protocol, AFR signals from the femoral
artery were also monitored, and, if necessary, to maintain a
stable arterial AFR signal, the ascorbate infusion rate was
adjusted before coronary occlusion. The infusion rate was not
altered during the coronary occlusion-reperfusion sequence
(10). At the end of the protocol, myocardial risk areas were
determined through intracoronary Evans blue injection distal
to the point of arterial occlusion. The mass of the area stained
was divided by the total left ventricular mass to determine
percent left ventricular area at risk.
Two dogs receiving Mg had serum Mg levels drawn before
Mg infusion was begun, and again 10 min after infusion was
begun (i.e., 5 min after reperfusion was initiated)—the time
when the peak AFR increase was expected, based on our
earlier work (10).
To ascertain whether Mg could have a direct effect on the
AFR signal, we performed an in vitro experiment. We added
100 mM of freshly prepared ascorbate and 7 mg/mL of Mg21
(similar to the Mg21 concentration achieved in the animal
experiments, see later) to a solution of 50 mM phosphate
buffer (pH 7.4, air-saturated). The steady-state AFR EPR
signal was measured before and immediately after the addition
of Mg21.
Statistical analysis. The reperfusion data were analyzed
using the SAS/STAT procedure MIXED. The repeated-
measures analysis was performed involving two factors, treat-
ment (control vs. Mg groups), a between-animal factor, and
time, the repeated-measures factor. Comparisons of interest,
involving mean changes over time within each group and
treatment group comparisons at each time point, were evalu-
ated by estimation of mean contrasts and its corresponding
standard error and then tested using the t-test statistic. The p
values were adjusted using Bonferroni’s method to adjust for
the number of comparisons performed. All data are presented
as mean 6 SEM.
Results
There were no differences between the two groups with
respect to left ventricular area at risk as assessed by Evans blue
dye staining: 30.6 6 2.6% vs. 33.4 6 3.0% for Mg and control
dogs, respectively (p 5 NS).
In two dogs receiving Mg infusion, serum Mg levels in-
creased from 1.25 6 0.55 mg/dl (before Mg) to 7.25 6
0.85 mg/dl (10 min after the infusion was begun, 5 min after
reperfusion). There was a significant but modest decline in
systolic and diastolic blood pressure in the dogs receiving Mg
(Table 1). No heart block occurred and no intravenous pressor
support was administered.
Magnesium blunted the coronary sinus peak free radical
rise: at 4 min of reperfusion there was a 4.7 6 3.3% increase in
dogs receiving Mg vs. an 18.2 6 3.3% increase in control dogs
(p , 0.05, Fig. 1). Although the peak rise in AFR reflects the
flux of radicals present in the blood at that time point, the total
integrated area under each curve was proportional to the total
free radical flux during the time of reperfusion. With use of a
Simpson integration, the control area was 66.5 6 12.4 arbitrary
units, whereas the Mg area was 31.3 6 10.7 arbitrary units (p ,
0.05), an overall reduction in total radical flux by 53%).
In the two dogs that were studied with the closed-chest
Abbreviations and Acronyms
AFR 5 ascorbate free radical
CS 5 coronary sinus
EPR 5 electron paramagnetic resonance
LAD 5 left anterior descending
Mg 5 magnesium
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preparation—one control and one dog receiving Mg—peak
AFR increases were 30.2% and 12.1%, respectively.
In the in vitro experiment, performed to determine whether
Mg21 had any direct effect on the AFR signal, we observed no
change in the amplitude of the AFR signal with the addition of
Mg21 at a concentration similar to that achieved in the in vivo
animal experiments.
Discussion
The major finding of this study is that Mg attenuates AFR
increase (total oxidative stress) in an occlusion-reperfusion
canine model.
Mechanisms of magnesium’s effect. Magnesium may atten-
uate free radical production in one of two ways: It may directly
inhibit free radical production or it may facilitate scavenging of
free radicals. A recent study (11) showed that Mg inhibits
reduced nicotinamide-adenine dinucleotide phosphate oxi-
dase, an enzyme that produces superoxide radical; the effect of
Mg at higher concentrations was comparable to other metals
(such as copper) that are usually considered excellent inhibi-
tors of free radical generation by reduced nicotinamide-
adenine dinucleotide phosphate oxidase. This same study (11)
found that although Mg does facilitate free radical scavenging,
it does so at only a minimal level compared with other
scavengers such as the transition metal manganese. Thus, the
mechanism for Mg’s attenuation of free radicals may be
through inhibition of free radical production upon reperfusion
and not by direct scavenging of radicals already present.
Dickens et al. (12) showed that Mg deficiency within
endothelial cells increased cytotoxicity to oxyradicals beginning
at a relatively short 15 min of exposure to the free radicals,
compared with Mg-rich cells. Thus, Mg may also protect the
endothelial cell from oxyradical injury.
Kramer et al. (13) demonstrated that following a sequence
of global ischemia and reperfusion, isolated working hearts
from rats fed an Mg-deficient diet displayed greater levels of
radical adduct production in EPR spin-trapping experiments
and less recovery of cardiac function than hearts from rats fed
an Mg-sufficient diet. This prooxidant influence of Mg defi-
ciency is consonant with our study’s demonstration of an
apparent antioxidant effect of acute Mg administration before
an occlusion-reperfusion sequence.
Magnesium is a divalent cation and is a known cofactor in
over 300 enzymes. It is essential for all adenosine triphos-
phatase activity including movement of calcium across and
within cell membranes for cardiovascular tissue. Magnesium
may also confer benefit during acute occlusion-reperfusion
sequences by its action as a physiologic calcium channel
blocker (6,9,14). Magnesium inhibits calcium overload during
initial phases of reperfusion through inhibition of calcium
transport across most calcium channels (9).
Magnesium in our study had a modest but significant
arterial pressure-lowering effect. This may have contributed to
the attenuation of free radicals by reducing ischemia during
coronary occlusion.
The use of AFR to evaluate the effect of Mg on free radicals
assumes that there is no direct interaction between AFR and
Mg. We demonstrated this in an in vitro experiment.
The dose of Mg used for the current study was based on
previous clinical studies of myocardial infarction (Intravenous
Magnesium Intervention Trial-2) (8). We only evaluated one
Mg dose; a dose-response study would be an appropriate
future study.
Ascorbate free radicals as a parameter of free radical
generation. Our AFR method has some advantages over other
free radical measurement methods, especially spin-trapping
Figure 1. Increase in ascorbate free radical (AFR) after 20 min of
coronary occlusion followed by reperfusion. During reperfusion, the
nine dogs that received intravenous magnesium had a significantly
lower increase in ascorbate free radical than the nine control dogs that
did not receive magnesium.














Control dogs 116.7 6 6.1 120.6 6 8.2 75.0 6 3.1 77.2 6 5.3
Magnesium dogs 109.4 6 8.6 100.0 6 4.7* 70.5 6 8.1 56.1 6 3.3†
*p 5 0.05; †p , 0.05. Data presented are mean value 6 SEM.
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methods: no chemicals are added, no tissue biopsies are
necessary, and the method is real time. However, a disadvan-
tage is that we do not know which specific radical(s) are
suppressed, because the AFR method only allows determina-
tion of total oxidative stress, and does not identify individual
radicals (10). Kramer et al. (13) noted strong correlations
between post ischemic free radical production—which our
AFR technique measures—and markers of tissue injury, such
as lactate dehydrogenase release and percent recovery of
cardiac work.
To facilitate blood transit from the CS to the EPR spec-
trometer, we used larger bore tubing, which resulted in a
longer transit time from the CS to the EPR measuring device
in this study than in our previous studies (10). We attribute the
differences in this study’s control group peak AFR increase of
18% compared with control AFR increases of .30% in our
previous study (10) to the longer transit time. We have recently
performed additional experiments with shorter transit times
showing peak AFR increases comparable to our earlier stud-
ies.
Relevance of this study to clinical effects of magnesium.
The use of open-chest preparations is inevitably unphysiologic
to some degree. We studied two dogs percutaneously, without
a thoracotomy. In the control (saline infusion) dog, the peak
coronary occlusion increase in the AFR signal was greater than
the increase in AFR in the open-chest animals. The closed-
chest dog that received Mg had a lower AFR peak increase
than the open-chest dogs. No conclusions can be drawn from
only two experiments. These closed-chest experiments do show
the feasibility of studying Mg’s effect in a more physiologic
experimental preparation. Future studies, using such a clini-
cally relevant model, are necessary to confirm the beneficial
effect of Mg in sequences of myocardial ischemia and reper-
fusion.
Direct free radical suppression by antioxidants such as
superoxide dismutase and catalase has been shown to improve
ventricular function after an occlusion-reperfusion sequence in
animals (3,4). Clinical studies using doses of Mg similar to ours
have also shown cardioprotective effects, with reductions in
infarct size, preservation of ejection fraction and reduced
mortality. These clinical benefits are consonant with attenua-
tion of free radical(s) by Mg as our study found.
In summary, magnesium reduces AFR production in an
occlusion-reperfusion canine model. Our study is the first, to
our knowledge, to demonstrate suppression of free radicals in
an occlusion-reperfusion sequence by Mg in a real-time, whole
animal model. Magnesium warrants further evaluation as a
cardioprotective agent in the setting of myocardial ischemia
and reperfusion.
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